MEMBRANEBLUE Drug Patent Profile

When do Membraneblue patents expire, and when can generic versions of Membraneblue launch?

Membraneblue is a drug marketed by Dorc and is included in one NDA.

The generic ingredient in MEMBRANEBLUE is trypan blue. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the trypan blue profile page.

Summary for MEMBRANEBLUE

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	40
What excipients (inactive ingredients) are in MEMBRANEBLUE?	MEMBRANEBLUE excipients list
DailyMed Link:	MEMBRANEBLUE at DailyMed

US Patents and Regulatory Information for MEMBRANEBLUE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dorc	MEMBRANEBLUE	trypan blue	SOLUTION;OPHTHALMIC	022278-001	Feb 20, 2009		DISCN	Yes	No

Expired US Patents for MEMBRANEBLUE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Dorc	MEMBRANEBLUE	trypan blue	SOLUTION;OPHTHALMIC	022278-001	Feb 20, 2009
Dorc	MEMBRANEBLUE	trypan blue	SOLUTION;OPHTHALMIC	022278-001	Feb 20, 2009

International Patents for MEMBRANEBLUE

See the table below for patents covering MEMBRANEBLUE around the world.

Country	Patent Number	Title	Estimated Expiration
Australia	757318
Australia	3853799
Australia	774292
Canada	2332039	EMPLOI DE COLORANT VITAL POUR FACILITER DES INTERVENTIONS ENCHIRURGIE VITREO-RETINIENNE (THE USE OF A VITAL DYE FOR FACILITATING SURGICAL PROCEDURES FOR VITREO-RETINAL SURGERY)
Australia	3853699

MEMBRANEBLUE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for MembraneBlue

Introduction

MembraneBlue, a trypan blue ophthalmic solution, is used as an aid in ophthalmic surgery, specifically for staining epiretinal membranes during vitrectomy procedures. To understand the market dynamics and financial trajectory of MembraneBlue, it is essential to delve into the broader pharmaceutical and ophthalmic markets, as well as specific factors influencing its use and revenue.

Pharmaceutical Filtration and Ophthalmic Markets

The pharmaceutical filtration market, which includes various filtration products used in drug manufacturing, is experiencing significant growth. This growth is driven by the increasing demand for biologics, the expansion of the generic drug market, and advancements in filtration technologies[4].

Ophthalmic Diagnostic Agents Market

The ophthalmic diagnostic agents market, where MembraneBlue is categorized, is a subset of the larger ophthalmic drugs market. This market is influenced by the growing need for ophthalmic surgeries, particularly those related to retinal diseases.

Market Size and Growth

While specific financial data for MembraneBlue is not readily available, the overall ophthalmic diagnostic agents market is part of a larger pharmaceutical sector that is seeing substantial growth. The global pharmaceutical filtration market, for example, is projected to grow from $11.4 billion in 2024 to $18.1 billion by 2029, at a CAGR of 9.8%[4].

Key Drivers

Several factors drive the demand for ophthalmic diagnostic agents like MembraneBlue:

Increasing Ophthalmic Surgeries

The rise in ophthalmic surgeries, particularly vitrectomy procedures, drives the demand for diagnostic agents. As the global population ages, the incidence of retinal diseases increases, leading to more surgical interventions[5].

Technological Advancements

Advancements in ophthalmic surgery techniques and the development of new diagnostic tools contribute to the growth of the market. Innovations in staining solutions like MembraneBlue enhance surgical outcomes and patient safety.

Regulatory Environment

Regulatory requirements and approvals play a crucial role in the market dynamics of ophthalmic diagnostic agents. MembraneBlue, for instance, received its initial U.S. approval in 2004, and any changes in regulatory standards can impact its market position[5].

Competitive Landscape

The ophthalmic diagnostic agents market is competitive, with several products available for various ophthalmic procedures. MembraneBlue competes with other staining solutions and diagnostic agents, and its market share is influenced by factors such as efficacy, safety, and cost.

Financial Trajectory

While specific financial data for MembraneBlue is not available, we can infer its financial trajectory from broader market trends:

Revenue Growth

Given the growth in ophthalmic surgeries and the increasing demand for diagnostic agents, MembraneBlue is likely to see revenue growth. The overall pharmaceutical filtration market's CAGR of 9.8% from 2024 to 2029 suggests a positive financial outlook for related products[4].

Market Share

MembraneBlue's market share would depend on its competitive positioning, the quality of the product, and the satisfaction of ophthalmic surgeons. A strong brand reputation and continuous innovation can help maintain or increase its market share.

Regional Dynamics

The market for ophthalmic diagnostic agents is global, but regional dynamics play a significant role:

North America and Europe

These regions have well-established healthcare systems and a high demand for ophthalmic surgeries, making them significant markets for MembraneBlue.

Emerging Markets

Countries like India, China, and Brazil are expected to offer lucrative opportunities due to rising demand for pharmaceuticals and supportive government policies[4].

Challenges and Opportunities

Regulatory Challenges

Changes in regulatory requirements can impact the market dynamics of MembraneBlue. For instance, stricter FDA guidelines could affect its approval and usage.

Technological Innovations

Continuous innovation in ophthalmic diagnostic agents presents both opportunities and challenges. MembraneBlue must stay competitive by adopting new technologies and improving its product offerings.

Pricing and Reimbursement

Pricing and reimbursement policies, particularly those related to Medicare and other healthcare programs, can significantly impact the financial trajectory of MembraneBlue. For example, changes in Medicare Part B drug payment policies could affect the market uptake of ophthalmic diagnostic agents[2].

Key Takeaways

• Growing Demand: The increasing need for ophthalmic surgeries drives the demand for diagnostic agents like MembraneBlue.
• Technological Advancements: Innovations in ophthalmic surgery and diagnostic tools are crucial for market growth.
• Regulatory Environment: Regulatory approvals and changes can significantly impact the market position of MembraneBlue.
• Competitive Landscape: The market is competitive, and MembraneBlue must maintain its competitive edge through quality and innovation.
• Financial Outlook: The product is likely to see revenue growth aligned with the broader pharmaceutical filtration market trends.

FAQs

Q: What is MembraneBlue used for? A: MembraneBlue is used as an aid in ophthalmic surgery to stain epiretinal membranes during vitrectomy procedures.

Q: What drives the demand for MembraneBlue? A: The demand is driven by the increasing need for ophthalmic surgeries, particularly vitrectomy procedures, and advancements in ophthalmic surgery techniques.

Q: How does the regulatory environment impact MembraneBlue? A: Regulatory approvals and changes can significantly impact the market position and usage of MembraneBlue.

Q: What are the key regions for the market of MembraneBlue? A: North America and Europe are significant markets, while emerging markets like India, China, and Brazil offer growing opportunities.

Q: How do pricing and reimbursement policies affect MembraneBlue? A: Changes in Medicare Part B drug payment policies and other reimbursement schemes can impact the market uptake and financial trajectory of MembraneBlue.

Cited Sources

1. European Pharmaceutical Review: "Pharmaceutical membrane filtration market to value $10 billion by 2025"[1].
2. BluePath Solutions: "Medicare Part B Drug Trends and Payment Dynamics"[2].
3. Federal Trade Commission: "Generic Drug Industry Dynamics"[3].
4. BCC Research: "The Growing Pharmaceutical Filtration Market: Trends, Drivers, and Future Outlook"[4].
5. Drugs.com: "MembraneBlue: Package Insert / Prescribing Information"[5].